Barbara Mora

5.1k total citations
54 papers, 1.4k citations indexed

About

Barbara Mora is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Barbara Mora has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Barbara Mora's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Celiac Disease Research and Management (15 papers) and Kruppel-like factors research (14 papers). Barbara Mora is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Celiac Disease Research and Management (15 papers) and Kruppel-like factors research (14 papers). Barbara Mora collaborates with scholars based in Italy, United States and Spain. Barbara Mora's co-authors include Maria Cristina Mazzilli, Margherita Bonamico, Francesca Megiorni, Francesco Passamonti, Raffaella Nenna, P. Mariani, Mirella Ferri, Fabio Massimo Magliocca, Claudio Tiberti and M. Barbato and has published in prestigious journals such as Blood, The Journal of Immunology and The American Journal of Gastroenterology.

In The Last Decade

Barbara Mora

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Mora Italy 19 630 486 400 359 310 54 1.4k
Ibtissem Ghédira Tunisia 18 240 0.4× 241 0.5× 161 0.4× 251 0.7× 56 0.2× 70 885
Hemlata Varsani United Kingdom 20 115 0.2× 607 1.2× 103 0.3× 891 2.5× 106 0.3× 31 1.7k
Mehran Ghaderi Sweden 23 88 0.1× 179 0.4× 159 0.4× 471 1.3× 53 0.2× 57 1.4k
K. Henry United Kingdom 17 100 0.2× 205 0.4× 201 0.5× 282 0.8× 361 1.2× 42 1.3k
Roberta Riboni Italy 19 114 0.2× 234 0.5× 149 0.4× 185 0.5× 335 1.1× 40 1.1k
Emiko Komura Japan 11 208 0.3× 62 0.1× 276 0.7× 338 0.9× 333 1.1× 18 1.2k
Huaibin M. Ko United States 18 44 0.1× 212 0.4× 345 0.9× 454 1.3× 56 0.2× 48 1.1k
T A Waldmann United States 10 92 0.1× 203 0.4× 346 0.9× 240 0.7× 63 0.2× 15 1.3k
Rita Simone Italy 16 37 0.1× 202 0.4× 239 0.6× 534 1.5× 185 0.6× 22 1.0k
Rosario Alberto Caruso Italy 22 63 0.1× 129 0.3× 265 0.7× 440 1.2× 96 0.3× 89 1.4k

Countries citing papers authored by Barbara Mora

Since Specialization
Citations

This map shows the geographic impact of Barbara Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mora more than expected).

Fields of papers citing papers by Barbara Mora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mora. The network helps show where Barbara Mora may publish in the future.

Co-authorship network of co-authors of Barbara Mora

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mora. A scholar is included among the top collaborators of Barbara Mora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mora. Barbara Mora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biagioli, Valentina, Antonella Barone, Alessandra Iurlo, et al.. (2025). Validity and Reliability of the Self‐Care in MyeloProliferative Neoplasms Inventory (SC‐MPNI). European Journal of Cancer Care. 2025(1).
2.
Guglielmelli, Paola, Arianna Ghirardi, Alessandra Carobbio, et al.. (2025). Cytopenic overt primary myelofibrosis at presentation: Analysis of outcomes in the prospective, real‐world ERNEST‐2 registry. HemaSphere. 9(2). e70072–e70072.
3.
Mora, Barbara, et al.. (2025). CALR -mutated myeloproliferative neoplasms. Leukemia & lymphoma. 66(7). 1198–1210. 2 indexed citations
4.
Guglielmelli, Paola, Barbara Mora, Francesca Gesullo, et al.. (2024). Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American Journal of Hematology. 99(8). 1550–1559. 11 indexed citations
5.
Kuykendall, Andrew, Somedeb Ball, Barbara Mora, et al.. (2024). Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO Precision Oncology. 8(8). e2300593–e2300593. 3 indexed citations
6.
Mora, Barbara, et al.. (2024). Prognostic and Predictive Models in Myelofibrosis. Current Hematologic Malignancy Reports. 19(5). 223–235. 2 indexed citations
7.
Mora, Barbara & Francesco Passamonti. (2022). Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms. Current Hematologic Malignancy Reports. 17(5). 127–139. 6 indexed citations
8.
Guglielmelli, Paola, Arianna Ghirardi, Alessandra Carobbio, et al.. (2021). Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study. Blood Advances. 6(2). 373–375. 40 indexed citations
9.
Gagelmann, Nico, Francesco Passamonti, Christine Wolschke, et al.. (2021). Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis. Haematologica. 107(8). 1840–1849. 54 indexed citations
10.
Merli, Michele, Irene Defrancesco, Carlo Visco, et al.. (2020). Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma. Leukemia & lymphoma. 61(9). 2122–2128. 13 indexed citations
11.
Cassinat, Bruno, Barbara Mora, Emmanuelle Verger, et al.. (2020). Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Advances. 4(15). 3708–3715. 30 indexed citations
12.
Falasca, Francesca, Cinzia Dello Russo, Barbara Mora, et al.. (2016). Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients. AIDS Research and Human Retroviruses. 32(7). 654–657. 7 indexed citations
13.
Passamonti, Francesco, Domenica Caramazza, Barbara Mora, Rosario Casalone, & Margherita Maffioli. (2014). It is time to change thrombosis risk assessment for PV and ET?. Best Practice & Research Clinical Haematology. 27(2). 121–127. 12 indexed citations
14.
Megiorni, Francesca, Barbara Mora, Margherita Bonamico, et al.. (2008). HLA-DQ and risk gradient for celiac disease. Human Immunology. 70(1). 55–59. 134 indexed citations
15.
Giovannetti, Antonello, Marina Pierdominici, Francesca Mazzetta, et al.. (2007). Unravelling the Complexity of T Cell Abnormalities in Common Variable Immunodeficiency. The Journal of Immunology. 178(6). 3932–3943. 205 indexed citations
16.
Megiorni, Francesca, Paola Indovina, Barbara Mora, & Maria Cristina Mazzilli. (2005). Minor expression of fascin-1 gene (FSCN1) in NTera2 cells depleted of CREB-binding protein. Neuroscience Letters. 381(1-2). 169–174. 24 indexed citations
17.
Bonamico, Margherita, P. Mariani, E Thanasi, et al.. (2004). Patchy Villous Atrophy of the Duodenum in Childhood Celiac Disease. Journal of Pediatric Gastroenterology and Nutrition. 38(2). 204–207. 29 indexed citations
18.
Megiorni, Francesca, Barbara Mora, Paola Indovina, & Maria Cristina Mazzilli. (2004). Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method. Neuroscience Letters. 373(2). 105–109. 50 indexed citations
19.
Indovina, Paola, et al.. (2001). Absence of in vivo DNA-Protein interactions in the DQA2 and DQB2 promoter regions. Human Immunology. 62(5). 504–508. 3 indexed citations
20.
Petronzelli, Fiorella, et al.. (1996). Unusual HLA Typing in Celiac Disease. Disease Markers. 13(1). 61–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ibtissem Ghédira Breakdown of academic impact, for papers by Hemlata Varsani Breakdown of academic impact, for papers by Mehran Ghaderi Breakdown of academic impact, for papers by K. Henry Breakdown of academic impact, for papers by Roberta Riboni Breakdown of academic impact, for papers by Emiko Komura Breakdown of academic impact, for papers by Huaibin M. Ko Breakdown of academic impact, for papers by T A Waldmann Breakdown of academic impact, for papers by Rita Simone Breakdown of academic impact, for papers by Rosario Alberto Caruso
Rankless by CCL
2026